1. |
Hoitsma AJ, Woodle ES, Abramowicz D, et al. FTY720 combined with tacrolimus in de novo renal transplantation:1-year, multicenter, open-label randomized study[J]. Nephrol Dial Transplant, 2011, 26(11):3802-3805.
|
2. |
Yoshida Y, Tsuji T, Watanabe S, et al. Efficacy of combination treatment with fingolimod (FTY720) plus pathogenic autoantigen in a glucose-6-phosphate isomerase peptide (GPI325-339)-induced arthritis mouse model[J].Biol Pharm Bull, 2013, 36(11):1739-1746.
|
3. |
Kong Y, Wang H, Wang S, et al.FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells[J]. Inflammation, 2014, 37(4):1326-1336.
|
4. |
Takasugi N, Sasaki T, Ebinuma I, et al.FTY720/fingolimod, a sphingosine analogue, reduces amyloid-beta production in neurons. PLoS One, 2013, 8(5):64050. http://dx.plos.org/10.1371/journal.pone.0064050.
|
5. |
Noda H, Takeuchi H, Mizuno T. Fingolimod phosphate promotes the neuroprotective effects of microglia[J]. J Neuroimmunol, 2013, 256(1-2):13-18.
|
6. |
Collier RJ, Wang Y, Smith SS, et al. Complement deposition and microglial activation in the outer retina in light-induced retinopathy:inhibition by a 5-HT1A agonist[J]. Invest Ophthalmol Vis Sci, 2011, 52(11):8108-8116.
|
7. |
Ciesek S, Steinmann E, Manns MP, et al. The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase[J]. J Infect Dis, 2008, 198(7):1091-1093.
|
8. |
Qin X, Yue Z, Sun B, et al. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels[J]. Br J Pharmacol, 2013, 168(6):1294-1312.
|
9. |
Paugh SW, Cassidy MP, He H, et al. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-ethyl)-1, 3-propanediol, interact with the CB1 cannabinoid receptor[J]. Mol Pharmacol, 2006, 70(1):41-50.
|
10. |
Wang X, Fan J, Zhang M. Upregulation of SOX9 in Glial (Müller) cells in retinal light damage of rats[J]. Neurosci Lett, 2013, 556:140-145.
|
11. |
Tian L, Zhang L, Xia F. Hydrogen-rich saline ameliorates[J].Med Gas Res, 2013, 3(1):19.
|
12. |
Tanito M, Li F, Anderson RE. Protection of retinal pigment epithelium by OT-551 and its metabolite TEMPOL-H against light-induced damage in rats[J]. Exp Eye Res, 2010, 91(1):111-114.
|
13. |
倪颖勤, 姜春晖, 徐格致.大鼠视网膜光损伤模型中小胶质细胞的迁移及活化[J].复旦学报(医学版), 2011, 38(2):126-130, 135.
|
14. |
Zeng HY. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice[J]. Invest Ophthalmol Vis Sci, 2005, 46(8):2992-2999.
|
15. |
Liu Y, Yang X, Utheim TP, et al. Correlation of cytokine levels and microglial cell infiltration during retinal degeneration in RCS rats. PLoS One, 2013, 8(12):82061. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082061..
|
16. |
Ni YQ, Xu GZ, Hu WZ, et al. Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation[J]. Invest Ophthalmol Vis Sci, 2008, 49(6):2589-2598.
|
17. |
Kitaoka S, Furuyashiki T. Roles of inflammation-related molecules in emotional changes induced by repeated stress[J]. Nihon Shinkei Seishin Yakurigaku Zasshi, 2014, 34(4):109-115.
|
18. |
Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases[J]. Brain Res Bull, 2012, 87(1):10-20.
|